Marking a quick clinical win with its $2.37 billion acquisition of Avadel, Alkermes reported on Tuesday that its Phase 3…

Pfizer and Alvinas have found a buyer for their newly approved breast cancer drug Vepanu, selling an exclusive worldwide license…

Since Roche launched Babismo, a long-acting eye disease treatment, in 2022, Bayer and Regeneron have hit sales of competing treatments…

Scientists have discovered a molecular “switch” in mice that turns on an energy-burning system hidden inside brown fat. This discovery…

SkillCare, a manufacturer of specialty healthcare products, on Tuesday announced the launch of the SkillCare Clinical Innovation Partnership (SCIP). The…